.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recently, researchers updated the VUMC algorithm for sickle cell disease identification to support gene therapy trials. Additionally, this automated tool utilizes electronic health record (EHR) data to create contemporaneous cohorts. Consequently, clinicians can compare outcomes between treated and untreated individuals. Historically, identifying these cohorts manually required significant resources. However, the updated algorithm streamlines this process with remarkable precision.
In this study, researchers evaluated 33,141 individuals of primarily African ancestry. Notably, the prevalence of SCD in this cohort was 1.4%. As a result, the VUMC algorithm demonstrated a sensitivity of 97.6% and a specificity of 99.9%. Furthermore, the positive predictive value (PPV) reached 98.9%. These metrics confirm the algorithm's reliability for large-scale clinical research.
Moreover, the tool distinguishes between specific SCD phenotypes. For instance, it achieved 96.8% sensitivity for HbSS/HbSβ0. In contrast, the sensitivity for HbSβ+ was 85%. Despite these variations, the specificity remained consistently high at 99.9% across all groups.
Therefore, accurate sickle cell disease identification is vital for evaluating newly approved gene therapies. Moreover, researchers need robust datasets to monitor long-term outcomes effectively. Therefore, this algorithm provides a scalable solution for healthcare systems globally. Ultimately, it enables the creation of high-fidelity cohorts without exhaustive manual chart reviews.
The algorithm uses a combination of ICD codes and laboratory data from electronic health records to identify and categorize patients with sickle cell disease.
The updated VUMC algorithm identifies the HbSS/HbSβ0 phenotype with a sensitivity of 96.8% and maintains a specificity of 99.9%.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Learn how the updated VUMC algorithm identifies sickle cell disease with >97% sensitivity using EHR data, aiding gene therapy outcome monitoring....
5 months ago
A large NHANES cohort study reveals that higher Healthy Eating Index scores significantly reduce all-cause mortality risk in CKD patients by 45%. This analysis highlights the importance of comprehensive diet quality and medical nutrition therapy in renal care to optimize long-term clinical survival.
Today
Explore real-world data showing how private oncogenetics and molecular tumor boards achieve 3-week consult turnaround, high ctDNA actionability, and vital germline variant detection, enhancing individualized cancer care and familial risk assessment.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
